Jeff Yass’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$817K Sell
17,600
-7,000
-28% -$252K ﹤0.01% 8728
2026
Q1
$603K Buy
24,600
+14,600
+146% +$346K ﹤0.01% 9188
2025
Q4
$248K Sell
10,000
-1,600
-14% -$42.5K ﹤0.01% 10395
2025
Q3
$329K Buy
+11,600
New +$314K ﹤0.01% 9906
2024
Q4
Sell
-5,600
Closed -$324K 13403
2024
Q3
$324K Buy
5,600
+100
+2% +$4.91K ﹤0.01% 9436
2024
Q2
$223K Sell
5,500
-5,700
-51% -$226K ﹤0.01% 10114
2024
Q1
$470K Buy
11,200
+4,100
+58% +$160K ﹤0.01% 8650
2023
Q4
$272K Buy
+7,100
New +$236K ﹤0.01% 10024
2022
Q4
Sell
-28,100
Closed -$1.1M 13872
2022
Q3
$1.1M Sell
28,100
-1,900
-6% -$87K ﹤0.01% 6407
2022
Q2
$1.16M Buy
30,000
+9,100
+44% +$346K ﹤0.01% 6160
2022
Q1
$1.01M Buy
20,900
+12,200
+140% +$629K ﹤0.01% 7085
2021
Q4
$639K Sell
8,700
-32,700
-79% -$2.69M ﹤0.01% 8495
2021
Q3
$3.77M Buy
+41,400
New +$3.52M ﹤0.01% 4473

Other funds holding ASTH

Jeff Yass's ASTH Position: Q2 2026 in Review

Jeff Yass increased its Astrana Health (ASTH) stake by 118% in Q2 2026, buying an estimated $1.49M and bringing the position to 76,338 shares worth $3.54M. The position accounts for ﹤0.01% of the portfolio, ranked #5290.

Jeff Yass first reported a position in ASTH in Q1 2018 and has held it in 23 quarters since. 207 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Jeff Yass held 76,338 shares of Astrana Health worth $3.54M as of Q2 2026.
  • Jeff Yass bought 41,271 Astrana Health shares in Q2 2026, an estimated $1.49M.
  • Astrana Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5290 holding.
  • Jeff Yass first reported a position in Astrana Health in Q1 2018 and has held it in 23 quarters since.
  • 207 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.